An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone with long-standing acne scarring and ongoing red, inflamed breakouts wrote about trying a bunch of peptide and topical treatments without seeing improvement. They list several short courses of different peptides and the addition of familiar skin medicines, but say their skin hasn’t gotten better. They’re asking for guidance or an explanation of what might be going on. A few of the things mentioned need a quick, plain explanation. GHK-Cu is a small peptide (a very short protein fragment) that’s often promoted for wound healing and skin repair; people use it to try to reduce scars and boost collagen. BPC-157 and TB-500 are other peptides sometimes touted for healing and inflammation, though they’re better known from animal studies and bodybuilding communities than from solid human clinical trials. KPV is another peptide fragment that some say can calm inflammation. Tretinoin is a prescription topical vitamin A product that speeds skin cell turnover and helps acne and scarring. Azelaic acid is a topical that reduces redness and some acne by calming inflammation and gently killing bacteria. The person also mentions eosinophilic gastritis (an inflammatory gut condition), which matters because it affects overall inflammation and what medicines someone can safely use. What the evidence actually shows is mixed and often limited. For tretinoin and azelaic acid, there’s good evidence in humans that they can improve acne and, over months, help some types of scarring and redness. The peptides—GHK-Cu, BPC-157, TB-500, KPV—have much less reliable human data. GHK-Cu has supportive lab and some small-scale human cosmetic studies, but not robust, large clinical trials proving it fixes acne scars. BPC-157 and TB-500 have promising results in animals and cell studies for healing, but human safety and effectiveness are poorly studied. KPV is mostly experimental. The person’s report—a few cycles, varying durations, and no clear benefit—fits what you’d expect when people try under-studied therapies: inconsistent results and uncertainty about dosing, delivery method, and whether the underlying problem is being treated. Why this matters to someone with persistent acne and scarring: proven topical drugs and procedures (like tretinoin, azelaic acid, certain laser or microneedling approaches, and dermatologist-supervised treatments) have predictable benefits for many people. Experimental peptides might sound promising, but they’re likely to be expensive, require many cycles, and may not work. Also, the presence of an inflammatory gut disease could change how someone’s skin reacts and how well treatments work. A sensible next step is to discuss with a dermatologist (and the gastroenterologist for the eosinophilic gastritis) to make a coordinated plan that considers proven therapies, realistic timelines (months), and safe options given the person’s other condition. There are important caveats and risks. Many peptides on the market are not FDA-approved for acne or scarring; quality, purity, and dosing can vary. Side effects are possible, and interactions with other conditions or medications aren’t well studied. Topicals like tretinoin can cause irritation, redness, and sensitivity to sunlight, so they need careful use and medical guidance. People with eosinophilic gastritis should tell their doctors about all treatments; systemic effects or immune interactions are not well understood for these peptides. If someone has tried several things without benefit, don’t assume the next unproven product will help—seek professional evaluation for other options like prescription therapies or in-office procedures. Bottom line: tried-and-true topical treatments plus a dermatologist’s plan are more reliable than experimental peptides; the peptides people list have limited human evidence, so discuss risks and realistic expectations with your doctors.
Source: r/Peptides